Literature DB >> 27442246

Routine Cancer Antigen 125 Surveillance-The Fatal Attraction of Testing.

James S Goodwin1.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27442246     DOI: 10.1001/jamaoncol.2016.2032

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

Review 1.  Combining drugs and extending treatment - a PFS end point is not sufficient.

Authors:  Bishal Gyawali; Vinay Prasad
Journal:  Nat Rev Clin Oncol       Date:  2017-05-23       Impact factor: 66.675

2.  Low-value practices in oncology contributing to financial toxicity.

Authors:  Bishal Gyawali
Journal:  Ecancermedicalscience       Date:  2017-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.